Whitegate Investment Counselors’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,131
| Closed | -$62K | – | 230 |
|
|
2021
Q2 | $62K | Hold |
1,131
| – | – | 0.01% | 220 |
|
|
2021
Q1 | $69K | Hold |
1,131
| – | – | 0.01% | 210 |
|
|
2020
Q4 | $81K | Hold |
1,131
| – | – | 0.01% | 206 |
|
|
2020
Q3 | $83K | Hold |
1,131
| – | – | 0.02% | 193 |
|
|
2020
Q2 | $99K | Hold |
1,131
| – | – | 0.02% | 189 |
|
|
2020
Q1 | $62K | Hold |
1,131
| – | – | 0.02% | 175 |
|
|
2019
Q4 | $93K | Sell |
1,131
-555
| -33% | -$45.6K | 0.02% | 198 |
|
|
2019
Q3 | $168K | Hold |
1,686
| – | – | 0.03% | 190 |
|
|
2019
Q2 | $190K | Hold |
1,686
| – | – | 0.04% | 189 |
|
|
2019
Q1 | $123K | Buy |
1,686
+333
| +25% | +$24.3K | 0.03% | 188 |
|
|
2018
Q4 | $127K | Buy |
1,353
+275
| +26% | +$25.8K | 0.03% | 183 |
|
|
2018
Q3 | $155K | Hold |
1,078
| – | – | 0.03% | 162 |
|
|
2018
Q2 | $174K | Hold |
1,078
| – | – | 0.04% | 183 |
|
|
2018
Q1 | $175K | Buy |
+1,078
| New | +$175K | 0.04% | 183 |
|